🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Chip Wilson, Lululemon founder, announced today he has committed $100M & created a new venture, SOLVE FSHD with the objective to accelerate finding a cure for facioscapulohumeral muscular dystrophy (#FSHD) by 2027. Chip was diagnosed with #FSHD2 at age 32. solvefshd.com/files/Solve%20…

We're committing $1M to n-Lorem Foundation to gain further insight into the molecular mechanisms that lead to FSHD2. The partnership will support research efforts to inform a therapeutic strategy for this complex disease. Read more about their pioneering work: bwnews.pr/3BTdKG8

We're excited to announce our partnership with Altay Therapeutics, which will help accelerate the discovery and development of much-needed therapies for FSHD. Read the press release and learn more on our website: solvefshd.com/news-updates

We are excited to support miRecule, Inc. and to be part of this unique and cutting edge approach to a disease-modifying therapy for FSHD. Learn more about miRecule's goals in identifying a muscle-specific antibody conjugated DUX4 inhibitor for FSHD. bit.ly/3C88Sf1

Today we announced our investment in Vita Therapeutics. This partnership will support Vita's cell therapy approach, which will stimulate muscle regeneration and help people build up muscle faster than it breaks down. Read more on our website. bit.ly/3TjFNV8

Today we announced our latest investment in @EpicBiotech. Epic's unique approach to correct the molecular pathology implicated in FSHD should lead to an effective treatment that prevents further muscle degeneration and thereby slows disease progression. solvefshd.com/news-updates/p…

It's World FSHD Day and FSHD Society has launched Project Mercury. This initiative is aimed at speeding the development of therapies to those affected by FSHD globally. Thanks for inviting our founder, Chip Wilson to share his #FSHD story.